Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

BACKGROUND: Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very limited in bladder cancer. RESULTS: We created the Genomics of Drug Sensitivity in Bladder...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Adnan Ahmad, Park, Inkeun, Kim, Inki, Park, Sojung, Ahn, Sung-Min, Lee, Jae-lyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Database
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171176/
https://www.ncbi.nlm.nih.gov/pubmed/30285760
http://dx.doi.org/10.1186/s12920-018-0406-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171176/
https://www.ncbi.nlm.nih.gov/pubmed/30285760
http://dx.doi.org/10.1186/s12920-018-0406-2

Ejemplares similares